Open AccessEvaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache
Author(s) -
Omid Hesami,
Seyedeh Simindokht Hosseini,
Nasim Kazemi,
Seyed-Mostafa Hosseini-Zijoud,
Nahid Beladi Moghaddam,
Farhad Assarzadegan,
S. Ahmad Mokhtari,
Shahrzad Fakhraee
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/16263.7339
Subject(s) - topiramate , medicine , migraine , ophthalmology , scheimpflug principle , headaches , anesthesia , cornea , surgery , epilepsy , psychiatry
Topiramate, a sulfa-derivative monosaccharide, is an antiepileptic drug which is administered in the control of migraine. It is reported to cause various ocular side effects such as visual field defect and myopic shift. To investigate the alterations in refractive error, properties of the cornea and changes in the anterior chamber in patients that receive Topiramate for migraine control.